COMP <GO>
INFU vs OSUR // ENTERPRISE SCALE & MARKET CAP
InfuSystems Holdings Inc. (NYSE) VS. OraSure Technologies Inc. (NASDAQ) • 15-METRIC TALLY: INFU 10
— OSUR 0
▲ ENTERPRISE SCALE & MARKET CAP LEADER: INFU
LAST: $14.07 (-2.63%) • MKT CAP: $287.8M
market-cap
$287.8M
LAST: $3.94 (-3.43%) • MKT CAP: $281.4M
market-cap
$281.4M
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (INFU VS. OSUR)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | INFU | OSUR | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 56.00% | 41.90% | +14.10 | INFU | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 12.80% | -35.00% | +47.80 | INFU | /roic <GO> |
| EV/EBITDA & P/E Valuation | 24.5x | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | 8.29% | -18.91% | +27.20 | INFU | /fcf-yield <GO> |
| Operating Margin | 8.30% | -60.00% | +68.30 | INFU | /operating-margins <GO> |
| Net Profit Margin | 4.60% | -59.80% | +64.40 | INFU | /net-margins <GO> |
| Revenue Growth (YoY) | 6.40% | -38.10% | +44.50 | INFU | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 5.16 | 2.47 | +2.69 | INFU | /balance-sheet <GO> |
| Piotroski F-Score Quality | 9/9 | 3/9 | +6.00 | INFU | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 63.5 | 57.0 | +6.50 | INFU | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 40.4x | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap ACTIVE | $287.8M | $281.4M | $6.4M | INFU | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | INFU REV | OSUR REV | INFU GROSS % | OSUR GROSS % | INFU FCF | OSUR FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $143.4M | $115.0M | 56.0% | 41.9% | $23.8M | -$53.2M |
| FY 2024 | $134.9M | $185.8M | 52.2% | 42.7% | $19.4M | $23.6M |
| FY 2023 | $125.8M | $405.5M | — | — | $11.2M | $141.6M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
INFU // BETA —
OSUR // BETA —